Literature DB >> 25105734

Activin A, B, and AB increase human trophoblast cell invasion by up-regulating N-cadherin.

Yan Li1, Christian Klausen, Jung-Chien Cheng, Hua Zhu, Peter C K Leung.   

Abstract

CONTEXT: Inhibin β-subunits and activin receptors are expressed by human trophoblast cells. Although activin A has been shown to enhance human trophoblast cell invasion, whether two additional activin isoforms, activin B and AB, exert similar effects remains unknown. Moreover, whether the expression of mesenchymal adhesion molecule neural cadherin (N-cadherin) is essential for this proinvasive effect of activin has yet to be determined.
OBJECTIVE: To examine the effects of all three activin isoforms on human trophoblast cell invasion and the involvement of N-cadherin.
DESIGN: HTR8/SVneo immortalized extravillous cytotrophoblast cells and primary cultures of human extravillous cytotrophoblast cells were used as study models. Small interfering RNA-mediated knockdown approaches were used to investigate the molecular determinants of activin-mediated functions.
SETTING: An academic research center. MAIN OUTCOME MEASURES: Reverse transcription-quantitative real-time PCR and Western blot analysis were used to examine mRNA and protein levels, respectively. Cell invasiveness was assessed by Matrigel-coated transwell assays.
RESULTS: All three activin isoforms produced comparable increases in HTR8/SVneo cell invasion as well as N-cadherin expression. In addition, the up-regulatory effect of activin isoforms on N-cadherin was confirmed in primary cultures of human trophoblast cells. Interestingly, small interfering RNA-mediated down-regulation of N-cadherin attenuated basal and activin-induced invasion of both HTR8/SVneo and primary trophoblast cells. All three activin isoforms induced equivalent phosphorylation of SMAD2 and SMAD3. Importantly, activin-stimulated cell invasion, up-regulation of N-cadherin, as well as activation of SMAD2/SMAD3 were abolished by the TGF-β type I receptor inhibitor SB431542 in HTR8/SVneo cells. Furthermore, knockdown of SMAD2/3 or common SMAD4 abolished the stimulatory effects of all three activin isoforms on N-cadherin expression.
CONCLUSION: Activin A, B, and AB produce comparable increases in human trophoblast cell invasion by up-regulating N-cadherin expression in a SMAD2/3-SMAD4-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25105734     DOI: 10.1210/jc.2014-2118

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

2.  N-cadherin knockdown leads to disruption of trophoblastic and endothelial cell interaction in a 3D cell culture model - New insights in trophoblast invasion failure.

Authors:  A Multhaup; B Huppertz; C Göhner; M Böhringer; M Mai; U Markert; E Schleußner; T Groten
Journal:  Cell Adh Migr       Date:  2017-12-12       Impact factor: 3.405

3.  GDF-11 promotes human trophoblast cell invasion by increasing ID2-mediated MMP2 expression.

Authors:  Ze Wu; Lanlan Fang; Sizhu Yang; Yibo Gao; Zhen Wang; Qingxue Meng; Xuan Dang; Ying-Pu Sun; Jung-Chien Cheng
Journal:  Cell Commun Signal       Date:  2022-06-15       Impact factor: 7.525

Review 4.  Integration of molecules to construct the processes of conceptus implantation to the maternal endometrium.

Authors:  K Imakawa; R Bai; K Kusama
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

5.  Mesenchymal-to-epithelial transition in the placental tissues of patients with preeclampsia.

Authors:  Lili Du; Liyun Kuang; Fang He; Wenting Tang; Wen Sun; Dunjin Chen
Journal:  Hypertens Res       Date:  2016-08-11       Impact factor: 3.872

6.  Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.

Authors:  Andreia Bufalino; Nilva K Cervigne; Carine Ervolino de Oliveira; Felipe Paiva Fonseca; Priscila Campioni Rodrigues; Carolina Carneiro Soares Macedo; Lays Martin Sobral; Marcia Costa Miguel; Marcio Ajudarte Lopes; Adriana Franco Paes Leme; Daniel W Lambert; Tuula A Salo; Luiz Paulo Kowalski; Edgard Graner; Ricardo D Coletta
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

7.  Role of activins in embryo implantation and diagnosis of ectopic pregnancy: a review.

Authors:  Bassem Refaat
Journal:  Reprod Biol Endocrinol       Date:  2014-11-25       Impact factor: 5.211

Review 8.  The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation.

Authors:  Tina Napso; Hannah E J Yong; Jorge Lopez-Tello; Amanda N Sferruzzi-Perri
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

9.  Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.

Authors:  Siyuan Xiong; Christian Klausen; Jung-Chien Cheng; Hua Zhu; Peter C K Leung
Journal:  Oncotarget       Date:  2015-10-13

10.  Bone morphogenetic protein 2 promotes human trophoblast cell invasion by upregulating N-cadherin via non-canonical SMAD2/3 signaling.

Authors:  Hong-Jin Zhao; Christian Klausen; Yan Li; Hua Zhu; Yan-Ling Wang; Peter C K Leung
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.